NCT03741595 is a NA clinical trial of Item spacing in Visual Pathway Disorder, sponsored by University of Houston.

Who is sponsoring NCT03741595?

NCT03741595 is sponsored by University of Houston.

What drugs are being tested in NCT03741595?

Interventions in NCT03741595: Item spacing.

What condition does NCT03741595 study?

NCT03741595 studies Visual Pathway Disorder.

Is NCT03741595 still recruiting?

NCT03741595 is currently status unknown. Last updated 15 November 2018.

Last reviewed 2018-11-15 · How we verify

NCT03741595

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Visual Stimulus Competition

Status unknown NA Last updated 15 November 2018

What this trial tests

NA trial testing Item spacing in Visual Pathway Disorder in 10 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
1 November 2019

1 November 2019

Quick facts

Lead sponsor	University of Houston
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	10
Start date	1 November 2018
Primary completion	1 November 2019
Estimated completion	1 November 2019
Sites	1 location across United States

Drugs / interventions tested

Item spacing

Conditions studied

Visual Pathway Disorder — all drugs for Visual Pathway Disorder →

Sponsor

University of Houston

Who can join

Eligibility, any sex, with Visual Pathway Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we will use behavioral methods to investigate several types of interactions that occur when visual stimuli conflict, such as when objects are presented nearby to each other, or to separate eyes. We will target purely sensory aspects by using simple geometric shapes: letters and lines. Our outcome measure will be performance thresholds.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Houston trials

Trials by the same sponsor.

NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
NCT07025772 — Shaping Habitual Impulses For a Tobacco-free Style · NA · recruiting
NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03741595 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Houston
Last refreshed: 15 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03741595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing